
    
      Phase 4, Open-label, Safety, Tolerability And Pharmacokinetic Study Of methylphenidate
      Hydrochloride (HCl) Extended Release Chewable Tablets (ERCT) In 4-5 Year Old Children With
      Attention Deficit Hyperactivity Disorder (ADHD)
    
  